產(chǎn)品詳情
簡單介紹：
Anti-Phospho-Paxillin(Ser83)抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Phospho-Paxillin(Ser83)抗體用于**組化實驗,WB實驗,相應(yīng)的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Phospho-Paxillin(Ser83)
Cat. Number:
Anti-Phospho-Paxillin(Ser83)抗體KL-10992R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Paxillin is a 64 kDa cytoskeletal adapter protein involved in organisation and function of focal adhesions, which are critical to cell adhesion and migration. This in turn plays a role in a wide variety of processes including embryogenesis, organogenesis, wound repair, inflammation and cancer. Paxillin contains LD motifs, LIM domains, SH3 and SH2 binding domains that serve as docking sites for cytoskeletal proteins, tyrosine Anti-Phospho-Paxillin(Ser83)抗體kinases (e.g., FAK, Pyk 2, Src), serine/threonine kinases, GTPase activating proteins and other adaptor proteins (e.g., Actin, Vinculin, Crk).
Also known as:
PXN(phospho S83); Paxillin (phospho S83); Paxillin (phospho Ser83); p-Paxillin (Ser83); Paired box protein Pax 1; PAX 1; PAX1; Anti-Phospho-Paxillin(Ser83)抗體Paxillin alpha; PXN; PXN protein; FLJ16691; FLJ23042; FLJ16691; PAXI_HUMAN; Paxillin; PXN protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Cow, .
●
Immunogen: KLH conjugatedAnti-Phospho-Paxillin(Ser83)抗體 synthetic peptide derived from human Phospho-Paxillin(Ser83).
●
Predicted Molecular Weight: 68kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Phospho-Paxillin(Ser83)抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Phospho-Paxillin(Ser83)抗體
Optimal working dilutions must be determined by the end user.
